المؤلفون: Iriemenam NC; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria., Ige FA; Microbiology Department, Center for Human Virology and Genomics, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria., Greby SM; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria., Mpamugo A; University of Maryland, Baltimore, Abuja, Nigeria., Abubakar AG; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria., Dawurung AB; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria., Esiekpe MK; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria., Thomas AN; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria., Okoli MU; National Reference Laboratory, Nigeria Centre for Disease Control Abuja, Abuja, Nigeria., Awala SS; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria., Ugboaja BN; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria., Achugbu CC; National Reference Laboratory, Nigeria Centre for Disease Control Abuja, Abuja, Nigeria., Odoh I; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria., Nwatu FD; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria., Olaleye T; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria., Akayi L; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria., Akinmulero OO; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria., Dattijo J; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria., Onokevbagbe E; University of Maryland, Baltimore, Abuja, Nigeria., Okunoye O; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria., Mba N; National Reference Laboratory, Nigeria Centre for Disease Control Abuja, Abuja, Nigeria., Agala NP; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria., Uwandu M; Microbiology Department, Center for Human Virology and Genomics, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria., Aniedobe M; Microbiology Department, Center for Human Virology and Genomics, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria., Stafford KA; University of Maryland School of Medicine, Baltimore, MD, United States of America., Abimiku A; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria.; University of Maryland School of Medicine, Baltimore, MD, United States of America., Hamada Y; Institute for Global Health, University College London, London, United Kingdom., Swaminathan M; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria., Okoye MI; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria., Steinhardt LC; Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Audu R; Microbiology Department, Center for Human Virology and Genomics, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.

المصدر: PloS one [PLoS One] 2022 Apr 01; Vol. 17 (4), pp. e0266184. Date of Electronic Publication: 2022 Apr 01 (Print Publication: 2022).

نوع المنشور: Journal Article; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/diagnosis , COVID-19*/epidemiology , Pandemics*, Antibodies, Viral ; Humans ; Immunoglobulin G ; Nigeria/epidemiology ; SARS-CoV-2 ; Sensitivity and Specificity ; Seroepidemiologic Studies